4//SEC Filing
Graham G. Walmsley 4
Accession 0000935836-24-000763
CIK 0001750284other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 7:52 PM ET
Size
7.6 KB
Accession
0000935836-24-000763
Insider Transaction Report
Form 4
Graham G. Walmsley
Director
Transactions
- Purchase
Common Stock
2024-12-17$6.75/sh−700,761$4,730,137→ 1,408,875 total(indirect: See note) - Sale
Common Stock
2024-12-17$6.75/sh−700,761$4,730,137→ 0 total(indirect: See note)
Footnotes (3)
- [F1]The shares are held by Logos Opportunities Fund I LP ("Logos Fund I"). Logos Opportunities GP, LLC ("Logos Opportunities GP") is the general partner of Logos Fund I and the reporting person is a managing member of Logos Opportunities GP. The reporting person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
- [F2]The shares are held by Logos Opportunities Fund IV LP ("Logos Fund IV"). Logos Opportunities IV GP LLC ("GP IV") is the general partner of Logos Fund IV and the reporting person is a managing member of GP IV. The reporting person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
- [F3]These securities were sold by Logos Fund I to Logos Fund IV. Logos Fund I and Logos Fund IV are under the common control of the Reporting Person.
Documents
Issuer
Olema Pharmaceuticals, Inc.
CIK 0001750284
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001777517
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 7:52 PM ET
- Size
- 7.6 KB